Home > National Drug Code (NDC) > Broncotron PED

Broncotron PED - 11026-2790-2 - (Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl)

Alphabetical Index


Drug Information of Broncotron PED

Product NDC: 11026-2790
Proprietary Name: Broncotron PED
Non Proprietary Name: Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl
Active Ingredient(s): 5; 100; 2.5    mg/5mL; mg/5mL; mg/5mL & nbsp;   Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl
Administration Route(s): ORAL
Dosage Form(s): SOLUTION/ DROPS
Coding System: National Drug Codes(NDC)

Labeler Information of Broncotron PED

Product NDC: 11026-2790
Labeler Name: Seyer Pharmatec, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number: part341
Marketing Category: OTC MONOGRAPH FINAL
Start Marketing Date: 20121215

Package Information of Broncotron PED

Package NDC: 11026-2790-2
Package Description: 1 BOTTLE, DROPPER in 1 CARTON (11026-2790-2) > 60 mL in 1 BOTTLE, DROPPER

NDC Information of Broncotron PED

NDC Code 11026-2790-2
Proprietary Name Broncotron PED
Package Description 1 BOTTLE, DROPPER in 1 CARTON (11026-2790-2) > 60 mL in 1 BOTTLE, DROPPER
Product NDC 11026-2790
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl
Dosage Form Name SOLUTION/ DROPS
Route Name ORAL
Start Marketing Date 20121215
Marketing Category Name OTC MONOGRAPH FINAL
Labeler Name Seyer Pharmatec, Inc.
Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
Strength Number 5; 100; 2.5
Strength Unit mg/5mL; mg/5mL; mg/5mL
Pharmaceutical Classes

Complete Information of Broncotron PED


General Information